Bradycardia during critical care intubation: mechanisms, significance and atropine

Area of Science:

• Pediatric Critical Care
• Anesthesiology
• Pharmacology

Background:

• Bradycardia during pediatric intubation can result from vagal stimulation (hypoxia, laryngeal) causing vasoconstriction, or from induction drugs causing vasodilation.
• Unstable bradycardia, unresponsive to re-oxygenation, may progress with certain pathologies and drug-induced vasodilation.
• Preintubation atropine reduces stable bradycardia in routine anesthesia but is less effective in critical care settings, particularly with vasodilation.

Purpose of the Study:

• To evaluate the efficacy of atropine in preventing bradycardia during critical care intubation in children.
• To determine if atropine administration is warranted for all critical care intubations.

Main Methods:

• Review of clinical studies on critical care intubation in children.
• Analysis of bradycardia mechanisms, including vagal stimulation, hypoxia, laryngeal manipulation, and drug effects (vasoconstriction/vasodilation).

Main Results:

• Atropine diminishes stable bradycardia in routine anesthesia but does not prevent all episodes during critical care intubation.
• Atropine does not counteract bradycardia associated with drug-induced vasodilation.
• Evidence is insufficient to recommend routine atropine use for all critical care intubations, including neonatal respiratory distress.

Conclusions:

• Atropine is not universally effective in preventing bradycardia during critical care intubation, especially when vasodilation is a factor.
• Specific indications for atropine include septic shock, hypovolemic shock, and premedication with suxamethonium.
• Indiscriminate use of atropine in critical care intubation is not supported by current evidence.